Common use of Minimum Revenue Clause in Contracts

Minimum Revenue. Borrower and its Subsidiaries shall have annual Revenue from sales of the Product and the licensing of any underlying Obligor Intellectual Property (for each respective calendar year, the “ Minimum Required Revenue ”): (a) during the twelve month period beginning on January 1, 2017, of at least $[***]; (b) during the twenty-four month period beginning on January 1, 2017, of at least $[***]; (c) during the twenty-four month period beginning on January 1, 2018, of at least $[***]; (d) during the twenty-four month period beginning on January 1, 2019, of at least $[***]; and (e) during the twenty-four month period beginning on January 1, 2020, of at least $[***].

Appears in 1 contract

Sources: Term Loan Agreement (T2 Biosystems, Inc.)

Minimum Revenue. Borrower and its Subsidiaries The Obligors shall have annual Revenue from sales of the Product and the licensing of any underlying Obligor Intellectual Property Products (for each respective calendar year, the Minimum Required Revenue Revenue”): (a) during the twelve month period beginning on January 1, 2017, of at least $[****]; (b) during the twenty-four month period beginning on January 1, 2017, of at least $[***]; (c) during the twenty-four twelve month period beginning on January 1, 2018, of at least $[****]; (dc) during the twenty-four twelve month period beginning on January 1, 2019, of at least $[***]; and (e) during the twenty-four month period beginning on January 1, 2020, of at least $[***].;

Appears in 1 contract

Sources: Term Loan Agreement (Strongbridge Biopharma PLC)

Minimum Revenue. Borrower and its Subsidiaries shall have annual Product Revenue from sales of the Product and the licensing of any underlying Obligor Intellectual Property (for each respective calendar year, the Minimum Required Revenue Revenue”): (a) during the twelve month period beginning on January 1, 2017, of at least $[***]; (b) during the twenty-four month period beginning on January 1, 2017, of at least $[***]; (c) during the twenty-four twelve month period beginning on January 1, 2018, of at least $[***]; (dc) during the twenty-four twelve month period beginning on January 1, 2019, of at least $[***]; and; (ed) during the twenty-four twelve month period beginning on January 1, 2020, of at least $[***]; (e) during the twelve month period beginning on January 1, 2021, of at least $***; and (f) during the twelve month period beginning on January 1, 2022, of at least $***.

Appears in 1 contract

Sources: Term Loan Agreement (Biodelivery Sciences International Inc)

Minimum Revenue. Borrower and its Subsidiaries shall have annual Revenue from sales of the Product and the licensing of any underlying Obligor Intellectual Property (for each respective calendar year, the Minimum Required Revenue Revenue”): (a) during the twelve month period beginning on January 1, 2017, of at least $[***]; (b) during the twenty-four month period beginning on January 1, 2017, of at least $[***]; (c) during the twenty-four month period beginning on January 1, 2018, of at least $[***]; (d) during the twenty-four month period beginning on January 1, 2019, of at least $[***]; and (e) during the twenty-four month period beginning on January 1, 2020, of at least $[***].

Appears in 1 contract

Sources: Term Loan Agreement (T2 Biosystems, Inc.)

Minimum Revenue. Borrower and its Subsidiaries The Obligors shall have annual Revenue from sales of the Product and the licensing of any underlying Obligor Intellectual Property Products (for each respective calendar year, the Minimum Required Revenue Revenue”): (a) during the twelve month period beginning on January 1, 2017, of at least $[****]; (b) during the twenty-four month period beginning on January 1, 2017, of at least $[***]; (c) during the twenty-four twelve month period beginning on January 1, 2018, of at least $[****]; (dc) during the twenty-four twelve month period beginning on January 1, 2019, of at least $[****]; and; (ed) during the twenty-four twelve month period beginning on January 1, 2020, of at least $[****]; (e) during the twelve month period beginning on January 1, 2021, of at least $[****]; and (f) during the twelve month period beginning on January 1, 2022, of at least $[****].

Appears in 1 contract

Sources: Term Loan Agreement (Strongbridge Biopharma PLC)